544 related articles for article (PubMed ID: 16952654)
21. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
22. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.
Comiter CV
J Urol; 2003 Apr; 169(4):1369-73. PubMed ID: 12629364
[TBL] [Abstract][Full Text] [Related]
23. Responsiveness of symptom scales for interstitial cystitis.
Propert KJ; Mayer RD; Wang Y; Sant GR; Hanno PM; Peters KM; Kusek JW;
Urology; 2006 Jan; 67(1):55-9. PubMed ID: 16413332
[TBL] [Abstract][Full Text] [Related]
24. Hyperbaric oxygen therapy for interstitial cystitis resistant to conventional treatments.
Tanaka T; Kawashima H; Makino T; Kamikawa S; Kato N; Nakatani T
Int J Urol; 2007 Jun; 14(6):563-5. PubMed ID: 17593107
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.
Sairanen J; Tammela TL; Leppilahti M; Multanen M; Paananen I; Lehtoranta K; Ruutu M
J Urol; 2005 Dec; 174(6):2235-8. PubMed ID: 16280777
[TBL] [Abstract][Full Text] [Related]
26. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis.
Nickel JC; Payne CK; Forrest J; Parsons CL; Wan GJ; Xiao X
J Urol; 2009 Jun; 181(6):2555-61. PubMed ID: 19375108
[TBL] [Abstract][Full Text] [Related]
27. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up.
Clarke RE; Tenorio LM; Hussey JR; Toklu AS; Cone DL; Hinojosa JG; Desai SP; Dominguez Parra L; Rodrigues SD; Long RJ; Walker MB
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):134-143. PubMed ID: 18342453
[TBL] [Abstract][Full Text] [Related]
28. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: a prospective, randomized, comparative study.
Gallego-Vilar D; García-Fadrique G; Povo-Martin I; Salvador-Marin M; Gallego-Gomez J
Urol Int; 2013; 90(4):411-6. PubMed ID: 23485788
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
[TBL] [Abstract][Full Text] [Related]
31. Efficiency of questionnaires used to screen for interstitial cystitis.
Kushner L; Moldwin RM
J Urol; 2006 Aug; 176(2):587-92. PubMed ID: 16813894
[TBL] [Abstract][Full Text] [Related]
32. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
33. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
Propert KJ; Mayer R; Nickel JC; Payne CK; Peters KM; Teal V; Burks D; Kusek JW; Nyberg LM; Foster HE;
J Urol; 2007 Sep; 178(3 Pt 1):886-90. PubMed ID: 17631335
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis.
Warren JW; Horne LM; Hebel JR; Marvel RP; Keay SK; Chai TC
J Urol; 2000 Jun; 163(6):1685-8. PubMed ID: 10799160
[TBL] [Abstract][Full Text] [Related]
35. Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial.
Nickel JC; Crossland A; Davis E; Haab F; Mills IW; Rovner E; Scholfield D; Crook T
J Urol; 2012 Sep; 188(3):817-23. PubMed ID: 22818144
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
37. [Hyperbaric oxygenation in combined treatment of interstitial cystitis].
Pushkar' DIu; Zaĭtsev AV; Gavrilenko AP; Matsaev AB; Kasian GR; Kolontarev KB; Farmanov RF
Urologiia; 2010; (1):22-4. PubMed ID: 20886727
[TBL] [Abstract][Full Text] [Related]
38. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study.
Rofeim O; Hom D; Freid RM; Moldwin RM
J Urol; 2001 Jul; 166(1):134-6. PubMed ID: 11435840
[TBL] [Abstract][Full Text] [Related]
39. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
40. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis.
Zhao J; Nordling J
BJU Int; 2004 Jul; 94(1):101-4. PubMed ID: 15217440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
